Capsaicin‐desensitization to the human nasal mucosa selectively reduces pain evoked by citric acid.
- 1 February 1993
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 35 (2) , 178-183
- https://doi.org/10.1111/j.1365-2125.1993.tb05683.x
Abstract
1. Kallidin (5‐500 nmol), hypertonic saline (0.9‐20% NaCl) or low pH medium (citric acid: pH 2.5‐1) applied (50 microliters) to the human nasal mucosa produced a pain response (evaluated by a visual analogue scale) that was related to the concentration of the peptide, NaCl or hydrogen ions, respectively. 2. Application (50 microliters) of capsaicin (50 nmol) to the human nasal mucosa produced overt pain. After repeated administrations (once a day for 5‐7 days) to one nostril this effect underwent almost complete desensitization, while in the contralateral nostril, treated with the vehicle, the response to capsaicin was unaffected. 3. The pain response produced in the human nasal mucosa by topical application (50 microliters) or kallidin (50‐ 500 nmol), NaCl (10‐20%) or citric acid (pH 1.5‐1) solutions was then studied before and after local capsaicin desensitization. 4. The pain response to pH 1.5 or 1 citric acid was markedly reduced (by 60% and 75%, respectively) in the capsaicin‐treated nostril. However, the pain response to 10% or 20% NaCl or the mild pain response to 50 or 500 nmol kallidin were unaffected by capsaicin pre‐treatment. 5. The present results suggest that prolonged topical capsaicin treatment to the human nasal mucosa may lead to selective desensitization to certain algesic stimuli such as capsaicin itself and hydrogen ions.Keywords
This publication has 27 references indexed in Scilit:
- The pharmacology of the efferent function of sensory nerves.Journal of Autonomic Pharmacology, 1991
- Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root anglion membranesBrain Research, 1990
- Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation.Journal of Clinical Investigation, 1990
- The post-mastectomy pain syndrome and the effect of topical capsaicinPain, 1989
- Ruthenium red selectively inhibits capsaicin-induced release of calcitonin gene-related peptide from the isolated perfused guinea pig lungNeuroscience Letters, 1989
- Beneficial Effect of Capsaicin Application to the Nasal Mucosa in Cluster HeadacheThe Clinical Journal of Pain, 1989
- Ruthenium Red selectively prevents capsaicin-induced nociceptor stimulationEuropean Journal of Pharmacology, 1989
- Post-herpetic neuralgia and topical capsaicinPublished by Wolters Kluwer Health ,1988
- Treatment of chronic postherpetic neuralgia with topical capsaicin: A preliminary studyJournal of the American Academy of Dermatology, 1987
- Pharmacologically induced selective degeneration of chemosensitive primary sensory neuronesNature, 1977